Listed

Owens Corning: Form 10-Q for the period ended Sep 30, 2024

Filed with the SEC on Nov 6, 2024 and accepted by EDGAR at Nov 6, 2024, 06:03 ET.

Share

Management's discussion and analysis

As filed, 5,415 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

On May 31, 2024, the Company issued $500 million of 2027 senior notes with an annual interest rate of 5.500%, $800 million of 2034 senior notes with an annual interest rate of 5.700% and $700 million of 2054 senior notes with an annual interest rate of 5.950%. These senior notes are net of discounts and issuance costs of $4 million, $11 million and $17 million, respectively. The proceeds from these notes were used to repay a portion of the outstanding borrowings under the 364-Day Credit Facility that was used to fund a portion of the purchase of Masonite in the second quarter of 2024 and to pay related fees and expenses.

On May 1, 2024, in connection with the acquisition of Masonite, we commenced an offer to exchange (the “Exchange Offer”) any and all of Masonite’s outstanding 3.50% Senior Notes due 2030 (the “Masonite 2030 notes”) for new 3.50% Senior Notes due 2030 of Owens Corning (the “Owens Corning 2030 notes”). On May 22, 2024, 99.51% of the outstanding Masonite 2030 notes were exchanged and we issued $373 million of aggregate principal amount of Owens Corning 2030 notes. Following the settlement of the Exchange Offer, approximately $2 million of the Masonite 2030 notes that were not exchanged remain outstanding, which has been recorded on the Consolidated Balance Sheets.

On April 15, 2024, in connection with the acquisition of Masonite, we commenced a tender offer (the “Tender Offer”) to purchase any and all of Masonite's outstanding 5.375% Senior Notes due 2028 (the “Masonite 2028 notes”) with an aggregate value of $501 million. On May 13, 2024, 94.25% of the outstanding Masonite 2028 notes were validly tendered, with Owens Corning making a cash payment on May 16, 2024 of approximately $480 million, inclusive of $7 million of interest and $1 million premium on tender. Following the settlement of the Tender Offer, approximately $29 million of the Masonite 2028 notes that were not tendered remain outstanding, which has been recorded on the Consolidated Balance Sheets.

On February 9, 2024, the Company announced the decision to review strategic alternatives for its global glass reinforcements (“GR”) business, consistent with our strategy to focus on building and construction materials. The GR business, which operates within our Composites segment, supplies a wide variety of glass fiber products for applications in wind energy, infrastructure, industrial, transportation, and consumer markets. The GR business generates annual revenues of approximately $1.3 billion. While a range of options are under consideration, including a potential sale, spin-off or other strategic option, there can be no assurance that the strategic review will result in any transaction or other outcome. During the first nine months of 2024, the Company incurred $33 million of costs related to this review.

During the second quarter of 2023, the Company’s subsidiary, Paroc Group OY (“Paroc”), which the Company acquired in 2018, notified the appropriate European maritime regulatory authorities that specific products in its marine insulation product line may not meet certain fire safety requirements in accordance with their certifications. Paroc voluntarily withdrew these specific products from the market, issued recalls, and suspended distribution and sales of these products (the “Recalled Products”). Paroc continues to cooperate with the applicable regulatory and government authorities and work with its customers and end-users to assist with remediation for the recall. During the first quarter of 2024, the Company discovered potential nonconformances relating to two other marine insulation product lines. In April 2024, Paroc suspended sales of these marine insulation products as a precautionary measure while it reviews the potential nonconformances, but has not issued recalls. The Company has included an estimated liability for expected future costs related to the Recalled Products on its Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023.

As part of its review of the Paroc insulation product portfolio, the Company discovered potential nonconformances relating to certain ventilation duct and steel beam insulation products. In January and September 2024, Paroc suspended sales of the affected insulation products as a precautionary measure while it reviews the potential nonconformances, but has not issued recalls. We expect to incur costs associated with the resolution of this matter. The amount or range of any potential loss cannot be reasonably estimated at this time. The Company is continuing its review.

On December 1, 2022, the Board of Directors approved a new share repurchase program under which the Company is authorized to repurchase up to an aggregate of 10 million shares of the Company’s outstanding common stock (the “Repurchase Authorization”). The Repurchase Authorization enables the Company to repurchase shares through the open market, privately negotiated, or other transactions. The actual number of shares repurchased will depend on timing, market conditions and other factors and will be at the Company’s discretion. The Company repurchased 1.2 million shares of its common stock for $202 million, inclusive of applicable taxes, in the third quarter of 2024 under the Repurchase Authorization. As of September 30, 2024, 6.9 million shares remained available for repurchase under the Repurchase Authorization.

Market risk

As filed, 291 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There has been no material change in our exposure to market risk during the nine months ended September 30, 2024. Please refer to “Quantitative and Qualitative Disclosures about Market Risk” contained in Part II, Item 7A of our 2023 Form 10-K for a discussion of our exposure to market risk.

Controls and procedures

As filed, 997 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company maintains (a) disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), and (b) internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act).

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures are effective.

There has been no change in the Company’s internal control over financial reporting during the quarter ended September 30, 2024 that materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2024-07-01 to 2024-09-30$3.05bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2024-01-01 to 2024-09-30$8.13bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2024-07-01 to 2024-09-30$2.14bnus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2024-01-01 to 2024-09-30$5.68bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2024-07-01 to 2024-09-30$908.0mus-gaap:GrossProfit
Gross profit9 months2024-01-01 to 2024-09-30$2.46bnus-gaap:GrossProfit
Research and development3 months2024-07-01 to 2024-09-30$36.0mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2024-01-01 to 2024-09-30$101.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2024-07-01 to 2024-09-30$279.0mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2024-01-01 to 2024-09-30$740.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2024-07-01 to 2024-09-30$509.0mus-gaap:OperatingIncomeLoss
Operating income9 months2024-01-01 to 2024-09-30$1.37bnus-gaap:OperatingIncomeLoss
Income tax3 months2024-07-01 to 2024-09-30$120.0mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2024-01-01 to 2024-09-30$318.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2024-07-01 to 2024-09-30$321.0mus-gaap:NetIncomeLoss
Net income9 months2024-01-01 to 2024-09-30$905.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2024-07-01 to 2024-09-30$3.65us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2024-01-01 to 2024-09-30$10.28us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-07-01 to 2024-09-30$3.69us-gaap:EarningsPerShareBasic
Basic EPS9 months2024-01-01 to 2024-09-30$10.38us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-07-01 to 2024-09-3087,900,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2024-01-01 to 2024-09-3088,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2024-01-01 to 2024-09-30$1.22bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2024-01-01 to 2024-09-30$450.0mus-gaap:PaymentsToAcquireProductiveAssets
Dividends paid9 months2024-01-01 to 2024-09-30$156.0mus-gaap:PaymentsOfDividends
Share repurchases9 months2024-01-01 to 2024-09-30$388.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2024-09-30$499.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2024-09-30$3.86bnus-gaap:AssetsCurrent
Total assetsAt period end2024-09-30$15.05bnus-gaap:Assets
Current liabilitiesAt period end2024-09-30$2.68bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-09-30$9.38bnus-gaap:Liabilities
Long-term debtAt period end2024-09-30$5.03bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2024-09-30$37.0mus-gaap:LongTermDebtCurrent
Short-term borrowingsAt period end2024-09-30$1.0mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2024-09-30$5.62bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001370946-24-000239. Last ingested by Listed: Nov 14, 2026, 12:03 ET. Listed shows no prices and gives no investment advice.